Company news
Corvus Pharmaceuticals, Inc. news in 2023
Corvus Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
December 8, 2023
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
November 6, 2023
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to T Cell-Mediated Inflammatory and Immune Diseases
October 31, 2023
Corvus Pharmaceuticals Confirms Planned Initiation of Soquelitinib (CPI-818) Phase 3 Registrational Clinical Trial in Peripheral T Cell Lymphoma Following Meeting with FDA
September 5, 2023
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
August 7, 2023
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter Financial Results on August 8, 2023
July 31, 2023
Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential Novel Approach to Immunotherapy Based on Inhibition of ITK with Soquelitinib (CPI-818)
July 5, 2023
Corvus Pharmaceuticals Presents New Ciforadenant Preclinical Data at the 2nd JCA-AACR Precision Cancer Medicine International Conference
June 28, 2023
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
May 7, 2023
Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 8, 2023
April 19, 2023
Corvus Pharmaceuticals Presents New CPI-818 Data Demonstrating the Potential of ITK Inhibition as a Treatment for Solid and Hematologic Cancers at the American Association for Cancer Research (AACR) Annual Meeting
April 16, 2023
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
March 27, 2023
Corvus Pharmaceuticals Announces New Data Demonstrating CPI-818’s (ITK Inhibitor) Potential to Block HIV Latency Reversal
February 20, 2023
Calls in 2023
- Corvus Pharmaceuticals (NASDAQ:CRVS) Q3 2023 Earnings Call
Nov 7, 2023
Transcript - Corvus Pharmaceuticals (NASDAQ:CRVS) Q2 2023 Earnings Call
Aug 8, 2023
Transcript - Corvus Pharmaceuticals (NASDAQ:CRVS) Q1 2023 Earnings Call
May 8, 2023
Transcript - Corvus Pharmaceuticals (NASDAQ:CRVS) Q4 2022 Earnings Call
Mar 28, 2023
Transcript